BARBARA PAGE: Open Payments
NPI 1538517941 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 5 payments from 4 companies in 2025. Trend: 2023 $583 · 2024 $223 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $195 |
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| ABBVIE INC. | 1 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: ARISTADA, REXULTI, VRAYLAR, LYBALVI, CAPLYTA.
Industry payments across MD — which companies pay providers there.
